Orphazyme A/S (ORPHA.CO)

DKK 1120.0

(-2.61%)

Annual Income Statements

(In DKK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - 36.19 Million - - -
Cost of Revenue - 782 Thousand 18.11 Million 5.19 Million 3.8 Million 1.36 Million
Gross Profit - -782 Thousand 18.08 Million -5.19 Million -3.8 Million -1.36 Million
Operating Expenses 27.04 Thousand 40.45 Million 669.49 Million 608.53 Million 335.95 Million 231.65 Million
Selling, General and Administrative Expenses 12.88 Thousand 40.45 Million 421.44 Million 342.19 Million 49.84 Million 75.33 Million
Research and Development Expenses - - 229.94 Million 261.13 Million 285.41 Million 154.95 Million
Other Expenses 14.15 Thousand - 18.11 Million 5.19 Million 699 Thousand 1.36 Million
Cost and Expenses 27.04 Thousand 41.24 Million 669.49 Million 608.53 Million 335.95 Million 231.65 Million
Operating Income -27.04 Thousand -41.24 Million -633.3 Million -608.53 Million -335.95 Million -231.65 Million
Interest Expense - - 9.45 Million 14.11 Million 4.8 Million 3.45 Million
Income Tax Expense -782.00 -2.75 Million -4.94 Million -1.91 Million -5.5 Million -5.5 Million
Earnings before Tax -26.04 Thousand -41.05 Million -631.48 Million -635.16 Million -342.99 Million -235.1 Million
Net Income -26.04 Million -110.59 Million -626.53 Million -633.24 Million -337.49 Million -229.6 Million
Earnings Per Share Basic -0.74 -3.14 -17.94 -22.32 -16.87 -11.47
Earnings Per Share Diluted -0.74 -3.14 -17.94 -22.32 -16.87 -11.47
Weighted Average Shares Outstanding 35 Million 35.26 Million 34.92 Million 28.36 Million 20 Million 20 Million
Weighted Average Shares Outstanding (Diluted) 35.31 Million 35.26 Million 34.92 Million 28.36 Million 20 Million 20 Million
Gross Margin - - 0.50 - - -
EBIT Margin - - -17.00 - - -
Profit Margin - - -17.31 - - -
EBITDA -26.04 Million -40.45 Million -603.91 Million -615.69 Million -334.31 Million -230.28 Million
Earnings Before Tax Margin - - -17.50 - - -

Income Statement Charts